Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Early vaccination reduces the risk of cervical cancer by nearly 90%, but many young people remain unprotected.
A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.
The agency emphasizes new therapies, prevention strategies and diagnostic advice for gonorrhea and other sexually transmitted infections.
Prolonged delays in cancer screening for low-income women during the pandemic threaten to increase existing health disparities.
In a new initiative, the Grammy-winning artist advises Black women to protect their cervical health with annual Pap and HPV tests.
The early cancer is detected, the easier it is to treat.
However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.
Mutations can affect how viruses behave and how well drugs and vaccines work.
A recent study analyzed immune responses to the HPV vaccine among HIV-positive youths 7 to 20 years old.
Compared with unvaccinated women, the risk among women vaccinated before age 17 dropped by almost 90%.
New guidelines assert that cervical cancer is best detected by a human papillomavirus test, but some groups disagree.
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
Oral STIs include chlamydia, gonorrhea, herpes simplex and human papillomavirus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.